Literature DB >> 29882545

Chronic Low Testosterone Levels in Endurance Trained Men: The Exercise- Hypogonadal Male Condition.

A C Hackney1, Eser Aggon2.   

Abstract

Entities:  

Year:  2018        PMID： 29882545      PMCID： PMC5988228     

Source DB:  PubMed          Journal:  J Biochem Physiol


× No keyword cloud information.
  4 in total

Review 1.  Overtraining in endurance athletes: a brief review.

Authors:  M Lehmann; C Foster; J Keul
Journal:  Med Sci Sports Exerc       Date:  1993-07       Impact factor: 5.411

2.  The presence of symptoms of testosterone deficiency in the exercise-hypogonadal male condition and the role of nutrition.

Authors:  David R Hooper; William J Kraemer; Catherine Saenz; Kevin E Schill; Brian C Focht; Jeff S Volek; Carl M Maresh
Journal:  Eur J Appl Physiol       Date:  2017-05-03       Impact factor: 3.078

Review 3.  Testosterone and endurance exercise: development of the "exercise-hypogonadal male condition".

Authors:  A C Hackney; A W Moore; K K Brownlee
Journal:  Acta Physiol Hung       Date:  2005

Review 4.  Effects of endurance exercise on the reproductive system of men: the "exercise-hypogonadal male condition".

Authors:  A C Hackney
Journal:  J Endocrinol Invest       Date:  2008-10       Impact factor: 4.256
  4 in total
  2 in total

1.  Testosterone undecanoate administration prevents declines in fat-free mass but not physical performance during simulated multi-stressor military operations.

Authors:  Alyssa N Varanoske; Melissa N Harris; Callie Hebert; Emily E Howard; Neil M Johannsen; Steven B Heymsfield; Frank L Greenway; Lee M Margolis; Harris R Lieberman; Robbie A Beyl; David D Church; Arny A Ferrando; Stefan M Pasiakos; Jennifer C Rood
Journal:  J Appl Physiol (1985)       Date:  2022-07-07

Review 2.  Late-onset hypogonadism: Clinical evidence, biological aspects and evolutionary considerations.

Authors:  Nikolai Jaschke; Andrew Wang; Lorenz C Hofbauer; Martina Rauner; Tilman D Rachner
Journal:  Ageing Res Rev       Date:  2021-02-18       Impact factor: 10.895
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.